Oslo Cancer Cluster - Company Review
Oslo Cancer Cluster - Company ReviewSummary
Oslo Cancer Cluster (Oslo Cancer) is a non-profit research organization that discovers and develops new therapies for oncology and cancer. The organization offers oncology research, cancer diagnostics and drug manufacturing services. Its projects include oncology clinical trials, Norwegian Immuno-Oncology Consortium, personalizes cancer medicine and National Cancer Drug Fund, among others. Oslo Cancer develops novel drugs targeting immuno-oncology. The organization partners with pharmaceutical companies, academic research institutions, biotech companies, university hospitals, universities, support groups and financial institutions. It collaborates with hospitals, research units and other sectors. The organization operates in Norway and Sweden. Oslo Cancer is headquartered in Lysaker, Norway.
This comprehensive company report of Oslo Cancer Cluster provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.